Nesco reports 26 per cent YoY growth in revenue
Nesco reports 26 per cent YoY growth in revenue

Nesco reports 26 per cent YoY growth in revenue

Amir Shaikh Article rating: 3.7

Nesco’s consolidated revenue for the fourth quarter of FY20 was up by 25.9 per cent YoY to Rs 117.75 crore. This was primarily due to 86 per cent YoY jump in the IT Park revenue

TCS launches product for students to take exams anywhere
TCS launches product for students to take exams anywhere

TCS launches product for students to take exams anywhere

Rishikesh Gaikwad Article rating: 3.6

TCS iONTM, a strategic unit of Tata Consultancy Services (TCS), announced the launch of remote assessments, a product that enables universities and exam boards to conduct secure, free and fair examinations at scale, in a remote model. The exam schedule of education institutions and exam conducting boards has been deeply impacted due to the current pandemic.

Lincoln Pharmaceuticals receive European Union GMP approval
Lincoln Pharmaceuticals receive European Union GMP approval

Lincoln Pharmaceuticals receive European Union GMP approval

Rishikesh Gaikwad Article rating: 2.5

Lincoln Pharmaceuticals Limited has received European Union (EU) GMP certification from Germany FDA for its manufacturing facility located at Khatraj (Gujarat). The certification will allow the company to market its products in all the 27 member countries of EU and also give an access to European Economic Area (EEA) countries. The company aims to enter EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.

Lupin launches Apriso generic equivalent in US market
Lupin launches Apriso generic equivalent in US market

Lupin launches Apriso generic equivalent in US market

Anthony Fernandes Article rating: 4.3

Pharma major Lupin Limited announced that it had launched an authorised generic version of Bausch Health’s Apriso (Mesalamine extended-release capsules 0.375 gm) in US Market.

Alembic JV receives USFDA nod for Clobetasol Propionate shampoo
Alembic JV receives USFDA nod for Clobetasol Propionate shampoo

Alembic JV receives USFDA nod for Clobetasol Propionate shampoo

Anthony Fernandes Article rating: 5.0

Alembic Pharmaceuticals Limited informed the bourses on Tuesday that its joint venture, Aleor Dermaceuticals Limited has received approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Clobetasol Propionate shampoo, 0.05 per cent.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 3.1

The market opened in the green on May 19, 2020. The previous trading session witnessed the Sensex down  by 1,068.75 points to end at 30,028.98 and the Nifty was down 313.60 points to close at 8,823.25.

Know more about stocks attracting fund managers
Know more about stocks attracting fund managers

Know more about stocks attracting fund managers

Henil Shah Article rating: 3.0

Everyone is eager to know what the mutual fund managers bought or sold and especially keen to know what they actually bought. So, here, we bring you a list of stocks that attracted the fund managers in the month of April 2020. Let’s find out.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 3.6

The market opened in the green on May 19, 2020. The previous trading session witnessed the Sensex down  by 1,068.75 points to end at 30,028.98 and the Nifty was down 313.60 points to close at 8,823.25.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 4.3

The market opened in the green on May 19, 2020, overall volumes in futures & options currently stand at 1,81 crore contracts with a turnover of Rs. 9,03,860.84 crore.

RSS
First22662267226822692271227322742275Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR